Brand: Huawei Technologies Co. Ltd., Bantian Huawei Base, Longgang District, Shenzhen, Guangdong 518129, CHINA.
Other: Huawei Device Co. Ltd., 2 Xincheng Road, Songshan Lake Zone, Dongguan, Guangdong 523808, CHINA.
Accuracy Assessment | Recommendation | Basis | |
BP | Medaval | ★★★ Recommendation | Recent clinical validation; recent protocol; multiple clinical validations |
BP | Stride BP | Self-measurement for adults | Published evidence |
Zhang W, Zhou YN, Zhou Y, Wang JG. Validation of the watch-type HUAWEI WATCH D oscillometric wrist blood pressure monitor in adult Chinese. Blood Press Monit. 2022 Oct 1;27(5):353-356. Epub: 2022 May 27. doi: 10.1097/MBP.0000000000000608. PMID: 35687029.
81060-2:2019 - Pass General population
Wang L, Xian H, Guo J, Li W, Wang J, Chen Q, Fu X, Li H, Chen Q, Zhang W, Chen Y. A novel blood pressure monitoring technique by smart HUAWEI WATCH: A validation study according to the ANSI/AAMI/ISO 81060-2:2018 guidelines. Front Cardiovasc Med. 2022 Oct 11;9:923655. doi: 10.3389/fcvm.2022.923655. PMID: 36304535. Available from: PMC9592900.
81060-2:2019 - Pass General population
Yi L, Lv ZH, Hu SY, Liu YQ, Yan JB, Zhang H, Li HB, Chen Q, Li YY, Jiang YF, Zhou H, Li MD, Chen RD, Li XL, Zhou SS, Chen YD. Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure. J Geriatr Cardiol. 2022 Nov 28;19(11):843-852. doi: 10.11909/j.issn.1671-5411.2022.11.004. PMID: 36561062. Available from: PMC9748271.
81060-2:2020 - Pass (n=85)
81060-2:2019 - Pass General population (Note: Stress study, as required for ABPM devices (n=35))
Lee WL, Danaee M, Abdullah A, Wong LP. Is the Blood Pressure-Enabled Smartwatch Ready to Drive Precision Medicine? Supporting Findings From a Validation Study. Cardiol Res. 2023 Dec;14(6):437-445. Epub: 2023 Dec 9. doi: 10.14740/cr1569. PMID: 38187511. Available from: PMC10769613.
81060-2:2019 (n=78) (Note: Protocol violations, including insufficient sample size and incorrect reporting of BP distribution (subjects instead of measurements), mean that this study must be considered as following a non-standard protocol.)